Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

CompletedOBSERVATIONAL
Enrollment

1,469

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 29, 2022

Study Completion Date

March 29, 2022

Conditions
MPN (Myeloproliferative Neoplasms)
Trial Locations (116)

Unknown

Huntsville

Tempe

Tucson

Little Rock

Berkeley

Highland

Long Beach

Oceanside

Palo Alto

Santa Rosa

Aurora

Colorado Springs

Fort Collins

Middletown

Washington D.C.

Aventura

Boynton Beach

Fort Lauderdale

Jacksonville

Pembroke Pines

Tampa

Winter Haven

Columbus

Marietta

Thomasville

Boise

Chicago

Elk Grove Village

Harvey

Maywood

Normal

River Forest

Skokie

Anderson

Avon

Indianapolis

Terre Haute

Ames

Topeka

Westwood

Danville

Mount Sterling

Paducah

Alexandria

Covington

Marrero

Rockport

Baltimore

Bethesda

Columbia

Boston

Worcester

Lansing

Jackson

Lansing

Bolivar

Cape Girardeau

Jefferson City

St Louis

Billings

Kalispell

Grand Island

Omaha

Las Vegas

Lebanon

Brick

East Orange

Florham Park

Morristown

Paramus

Albany

Brooklyn

East Setauket

Elmira

New York

Rochester

Staten Island

Boone

Charlotte

Durham

Greenville

Hendersonville

Canton

Cincinnati

Cleveland

Toledo

Tualatin

Bethlehem

Danville

Dunmore

Gettysburg

Pittsburgh

Willow Grove

Lancaster

Spartanburg

Watertown

Jackson

Amarillo

Arlington

Beaumont

Bryan

Dallas

Houston

McAllen

McKinney

Mesquite

Midland

San Antonio

Wichita Falls

Bristol

Seattle

Yakima

Martinsburg

Milwaukee

Bayamón

Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY